Study: Death rates after liver transplantation drop by more than 50% in the UK

In the past two decades, death rates after liver transplantation have dropped by more than half in the UK, according to a recent analysis of almost 10,000 liver transplant recipients published in BJS (British Journal of Surgery).

During this time period, survival over the first 3 years has improved to 83.1% in 2012-2016 (from 71.7% in 1997-2001) for patients who had transplants for cancer and to 90.7% (from 79.6%) for those transplanted for benign diseases.

The increase in survival after liver transplantation in the last 20 years can be explained by a combination of factors. There are improvements in short-time survival that are probably related to surgical technique and perioperative care, and improvements in long-term outcomes that are linked to developments in immunosuppression and follow-up care."

Nigel Heaton, MBBS, FRCS, Study Coauthor and Professor, King's College Hospital NHS Foundation Trust

Source:
Journal reference:

Wallace, D. (2020) Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK. British Journal of Surgery. doi.org/10.1002/bjs.11451.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exploring mouse models for studying liver fibrosis regression